Frunevetmab, a felinized anti‐nerve growth factor monoclonal antibody, for the treatment of pain from osteoarthritis in cats von Gruen, Margaret E., Myers, Jamie A. E., Tena, Jezaniah‐Kira S., Becskei, Csilla, Cleaver, Dawn M., Lascelles, B. Duncan X.

Volltext

A prospective, randomized, double-blind, placebo-controlled multisite, parallel-group field study in dogs with osteoarthritis conducted in the United States of America evaluating b... von Michels, Gina M., Honsberger, Nicole A., Walters, Rodney R., Kira S Tena, Jezaniah, Cleaver, Dawn M.

Volltext

A blinded, randomized, placebo-controlled trial of the efficacy and safety of the Janus kinase inhibitor oclacitinib (Apoquel®) in client-owned dogs with atopic dermatitis von Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Walsh, Kelly F., Follis, Stacey I., King, Vickie I., Tena, Jezaniah-Kira S., Stegemann, Michael R.

Volltext

Efficacy and safety of oclacitinib for the control of pruritus and associated skin lesions in dogs with canine allergic dermatitis von Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Martin, David D., Walsh, Kelly F., Harfst, Jessica A., Follis, Stacey L., King, Vickie L., Boucher, Joseph F., Stegemann, Michael R.

Volltext

Long-term compassionate use of oclacitinib in dogs with atopic and allergic skin disease: safety, efficacy and quality of life von Cosgrove, Sallie B., Cleaver, Dawn M., King, Vickie L., Gilmer, Amy R., Daniels, Anne E., Wren, Jody A., Stegemann, Michael R.

Volltext

A blinded, randomized, placebo‐controlled trial of the efficacy and safety of the J anus kinase inhibitor oclacitinib ( A poquel ® ) in client‐owned dogs with atopic dermatitis... von Cosgrove, Sallie B., Wren, Jody A., Cleaver, Dawn M., Walsh, Kelly F., Follis, Stacey I., King, Vickie I., Tena, Jezaniah‐Kira S., Stegemann, Michael R.

Volltext